12:00 AM
 | 
Nov 18, 2013
 |  BC Week In Review  |  Company News  |  Deals

Grifols, Novartis deal

Grifols will acquire Novartis' U.S.-based blood transfusion diagnostics unit for $1.7 billion. The unit provides nucleic acid testing, blood testing products and immunoassay reagents to detect infectious disease in blood donations for transfusion or to be used in the plasma...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >